Browse > Article
http://dx.doi.org/10.5012/bkcs.2010.31.7.1869

Synthesis, Molecular and Microstructural Study of Poly-N-Vinylpyrrolidone Oximo-L-Valyl-Siliconate with IR, 1H-NMR and SEM  

Singh, Man (Chemistry Research Lab, Deshbandhu College, University of Delhi)
Padmaja, G. Vani (Chemistry Research Lab, Deshbandhu College, University of Delhi)
Publication Information
Abstract
By reducing PVP with $H_2NOH$.HCl and NaOH 2:2:1 mass ratios in aqueous ethanol, poly-N-vinyl pyrrolidone oxime [PVPO] was prepared with 92% yield. Applying the sol-gel concept, orthosilicic acid [OSA] was made by hydrolyzing TEOS with ethanol in 1:0.5 molar ratios using 1 N KOH aqueous solution as a catalyst. The OSA + PVPO + $_L$-Valine ($\alpha$-amino acid) were mixed with pure ethanolic medium in 1:2:2 mass ratios and refluxed at $78^{\circ}C$ and 6 pH for 6.5 h. A white residue of poly-N-vinyl pyrrolidone oximo-L-valyl-siliconate [POVS] appeared after 5 h. The heating of reaction mixture was stopped and the contents were brought to NTP. The residue formation of POVS was intensified with lowering a temperature and completely solidified within 5 h, was filtered using a vacuum pump with Whatmann filter paper no. 42. The residue of POVS was washed several times with 20% aqueous cold ethanolic solution and dried in vacuum chamber at $25^{\circ}C$ for 24 h. The MP was noted above $350^{\circ}C$. Structural and internal morphology were analyzed with IR and $^1H$-NMR, and SEM respectively. A drug loading and transporting ability of the POVS in water and at pH = 5 and 8 was determined chromatographically.
Keywords
Poly-N-vinyl pyrrolidone oxime; Orthosilicic acid; TEOS; Poly-N-vinyl pyrrolidone oximo-$_L$-valylsiliconate; SEM;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Tan, X.; Li, M.; Cai, P.; Luo; L.; Zou, X. Anal. Biochem. 2005, 337, 111.   DOI
2 Smirnova, I.; Suttiruengwong, S.; Seiler, M.; Arlt, W. Pharmaceutical Development and Technology 2005, 9, 4443.
3 Watanabe, T.; Hasegawa, S.; Wakiyama, N.; Kusai, A.; Senna, M. Intern. J. Pharma. 2003, 250, 283.   DOI
4 Castro, R. P.; Cohen, Y.; Monbouquette, H. G. J. Memb. Sci. 1996, 115, 179.   DOI
5 Kei, T.; Hiromitsu, K. J. Sol-Gel Sci. Techn. 2004, 32, 1.
6 Hakan, P.; Torvard, C. L.; Torgny, L.; Lennart, K. Anal. Biochem. 1978, 88, 271.   DOI
7 Stephen, D. B. J. Biomed. Mater. Res. 2004, 7(5), 387.
8 Man, S.; Sushila, C. J. Appl. Polym. Sci. 2007, 104, 3261.   DOI
9 Man, S.; Vinod, K. J. Appl. Polym. Sci. 2009, 114, 1870.   DOI
10 Man, S.; Dolly, Y.; Rajesh K, Y. J. Appl. Polym. Sci. 2009, 110, 2601.
11 Singapore, Pat. No. 126089.
12 Feng, W.; He, H.; Timothy, J. B.; Christian, B.; Clive, A. P. Mol. Pharm. 2009.
13 Timoshenko, V. Y.; Kudryavtsev, A. A.; Osminkina, L. A.; Vorontsov, A. S.; Ryabchikov, Y. V.; Belogorokhov, I. A.; Kovalev, D.; Kashkarov, P. K. JETP Letters 2006, 83, 9.
14 Sergey, M. B.; Ingo, K. Analyst 2008, 133, 1302.   DOI